Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A (BRKRP)

About BRKRP

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle s…

Sector

Industrials

Industry

Biotechnology: Laboratory Analytical Instruments

Employees

11,085

Website

www.bruker.com/

Fundamentals

1-day range

$403.83$410.26

Market cap

$59.91B

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-0.47

Dividend yield

0.30%

Beta

1.24

Avg. volume

6.8K

Ex-dividend date

August 14, 2026

Dividend pay date

September 1, 2026

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A Competitors

Chosen by industry and closest market cap.

• BRKRP

  Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A

  $405.85

  ▼ 2.82%
  Market cap $59.91BP/E —
  $32.37$66.98
• A

  Agilent Technologies Inc. Common Stock

  $172.97

  ▼ 1.47%
  Market cap $39.92BP/E 34.26
  $108.35$177.05
• WAT

  Waters Corporation Common Stock

  $436.95

  ▼ 1.62%
  Market cap $39.24BP/E 260.32
  $282.77$454.54
• MTD

  Mettler-Toledo International Inc. Common Stock

  $1,622

  ▼ 1.02%
  Market cap $28.48BP/E 36.08
  $1,023$1,620
• RVTY

  Revvity Inc. Common Stock

  $152.64

  ▼ 1.34%
  Market cap $12.74BP/E 72.12
  $81.22$166.25
• BIO

  Bio-Rad Laboratories Inc. Class A Common Stock

  $353.7

  ▼ 3.05%
  Market cap $9.16BP/E 43.88
  $236.73$396.23
• AVTR

  Avantor Inc. Common Stock

  $16.42

  ▲ 2.05%
  Market cap $8.91BP/E —
  $7.27$16.38

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Why Is Bruker (BRKR) Getting Attention For Its Human Plasma Proteome Atlas?
  Yahoo · 10/9/2026
• Bruker (BRKR), Why Is Its Latest Update Drawing Fresh Attention?
  Yahoo · 10/8/2026
• Bruker Gains 66.3% in a Year: What's Driving the Rally?
  Yahoo · 10/8/2026
• 3 Cash-Producing Stocks We Steer Clear Of
  Yahoo · 10/7/2026
• Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution
  Yahoo · 10/6/2026
• Are Options Traders Betting on a Big Move in Bruker Stock?
  Yahoo · 10/5/2026
• 1 Surging Stock to Target This Week and 2 We Question
  Yahoo · 10/5/2026
• QIAGEN Expands US QIAstat-Dx Portfolio With New FDA-Cleared Panel
  Yahoo · 10/2/2026